Concept studied |
|
Impact of cost sharing on adherence |
44 (67%) |
Impact of cost sharing on adherence and outcomes |
22 (33%) |
|
Study design |
|
Retrospective |
56 (85%) |
Prospective |
9 (14%) |
Cross-sectional |
1 (2%) |
|
Population studied |
|
Commercially insured |
57 (86%) |
Medicare, other publicly insured |
9 (14%) |
|
Treatment or disease area studied |
|
Cardiovascular |
20 (31%) |
Diabetes |
5 (7%) |
Mental health |
3 (4%) |
Pulmonary |
3 (4%) |
Arthritis |
2 (3%) |
Infectious disease |
1 (2%) |
Gastrointestinal disease |
2 (3%) |
General |
30 (46%) |
|
Adherence: operational definition |
|
Number of filled prescriptions over a set time period |
25 (38%) |
Medication possession ratio (MPR) |
20 (30%) |
Combination of number of refills and medication possession ratio |
2 (4%) |
Patient self-report |
10 (15%) |
Other (i.e., initiation, discontinuation, elasticity) |
8 (12%) |
|
Relationship between cost sharing and adherence |
|
Statistically significant, inverse relationship |
56 (85%) |
No relationship or no statistically significant relationship |
10 (15%) |